Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-096780
Filing Date
2011-11-09
Accepted
2011-11-09 08:00:53
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c24254e10vq.htm 10-Q 194497
2 EXHIBIT 31.1 c24254exv31w1.htm EX-31.1 5936
3 EXHIBIT 31.2 c24254exv31w2.htm EX-31.2 5942
4 EXHIBIT 32.1 c24254exv32w1.htm EX-32.1 3419
  Complete submission text file 0000950123-11-096780.txt   1290459

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT ombp-20110930.xml EX-101.INS 143515
6 EX-101 SCHEMA DOCUMENT ombp-20110930.xsd EX-101.SCH 14414
7 EX-101 CALCULATION LINKBASE DOCUMENT ombp-20110930_cal.xml EX-101.CAL 33005
8 EX-101 LABELS LINKBASE DOCUMENT ombp-20110930_lab.xml EX-101.LAB 116813
9 EX-101 PRESENTATION LINKBASE DOCUMENT ombp-20110930_pre.xml EX-101.PRE 77033
10 EX-101 DEFINITION LINKBASE DOCUMENT ombp-20110930_def.xml EX-101.DEF 8943
Mailing Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111
Business Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111 (303) 867-3415
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-52530 | Film No.: 111189628
SIC: 2836 Biological Products, (No Diagnostic Substances)